L
Lee Edwards
Researcher at GlaxoSmithKline
Publications - 107
Citations - 2064
Lee Edwards is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Epithelial sodium channel & Cystic fibrosis. The author has an hindex of 25, co-authored 102 publications receiving 1673 citations. Previous affiliations of Lee Edwards include University of Manchester & University of Hertfordshire.
Papers
More filters
Patent
Am cyklischen Guanidin substituierte Amiloride Analoga als ENaC Blocker zur Behandlung von Atemwegserkrankungen
Gurdip Bhalay,Thomas Anthony Hunt,Paul Oakley,Nichola Smith,Emma Budd,Graham Charles Bloomfield,Stephen Paul Collingwood,Andrew Dunstan,Lee Edwards,Peter Gedeck,Catherine Howsham,Peter Hunt +11 more
Patent
Amiloride-like Pyrazine-carboxamides as ENaC blockers
Bhalay Gurdip,Emma Budd,Graham Charles Bloomfield,Collingwood Stephen Paul,Andrew Dunstan,Lee Edwards,Peter Gedeck,Catherine Howsham,Peter Hunt,Thomas Anthony Hunt,Paul Oakley,Nichola Smith +11 more
Patent
Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
Bhalay Gurdip,Thomas Anthony Hunt,Paul Oakley,Nichola Smith,Emma Budd,Graham Charles Bloomfield,Collingwood Stephen Paul,Andrew Dunstan,Lee Edwards,Peter Gedeck,Catherine Howsham,Peter Hunt +11 more
TL;DR: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel.
Journal ArticleDOI
Narrating the anxious market: in search of alternatives during global crises
TL;DR: The role, challenges and tensions that arise from the engagement of consumption and markets at the juncture of global crises are explored in this article . But the authors are sceptical of counter-market narratives that are appropriated by market mechanisms and look towards alternative forms of markets and consumption culture.
Patent
Pyrazine-2 carboxamide derivatives for treating diseases which respond to the blocade of the epithelial sodium channels
Bhalay Gurdip,Emma Budd,Graham Charles Bloomfield,Collingwood Stephen Paul,Andrew Dunstan,Lee Edwards,Peter Gedeck,Catherine Howsham,Peter Hunt,Thomas Anthony Hunt,Paul Oakley,Nichola Smith +11 more
TL;DR: In this article, the authors described compounds useful for treating diseases which respond to the blockade of the epithelial sodium channel, and pharmaceutical compositions that contain the compounds are also described, and they described the properties of the compounds.